Are there any side effects of BPC 157?

BPC 157 has potential side effects that you should be aware of:

1. Tumor Growth Risk: One major concern with BPC 157 is its capacity to promote angiogenesis (blood vessel growth) through the upregulation of vascular endothelial growth factor (VEGF). This mechanism is similar to that of some cancer treatments, which inhibit VEGF to shrink tumors. As BPC 157 increases VEGF levels, there is apprehension that it could also increase the risk of tumor growth and cancer 1.

2. Lack of Human Data: Research on BPC 157 is largely limited to animal studies, and there is insufficient human data to fully understand its long-term effects and potential risks. This absence of robust clinical evidence raises caution for potential users 1.

3. Experimental Use: Currently, BPC 157 is considered to be in a phase of widespread experimental use, with many individuals using it without proper oversight. Recommendations suggest taking the minimal effective dosage (300-500 micrograms a few times a week) rather than continuous daily use to reduce risks 1.

4. Monitoring Health Metrics: Users are encouraged to closely monitor their health for any signs that might resemble cancer or tumor growth as part of prudent usage. Regular health checks are advised to ensure safety while utilizing BPC 157 for recovery or performance enhancement 1.

These considerations underline the importance of being cautious and informed when contemplating the use of BPC 157.